Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04501913 · ClinicalTrials.gov registry record
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
A clinical trial of Clinical Stage II Esophageal Adenocarcinoma AJCC v8 and Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8, sponsored by City of Hope Medical Center.
- Completed
- Registry status
- 22
- Enrollment target
- 1
- Study location
NCT04501913 is a study of Clinical Stage II Esophageal Adenocarcinoma AJCC v8 and Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8 that has completed, run by City of Hope Medical Center. The registered enrollment target is 22 participants, below the 87-participant average among 10 other Clinical Stage II Esophageal Adenocarcinoma AJCC v8 trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04501913, a study of Clinical Stage II Esophageal Adenocarcinoma AJCC v8 and Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8, has completed, sponsored by City of Hope Medical Center.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
This study examines at-home monitoring of patient-generated phsyiologic health data and patient-reported outcomes. Patient-generated health data using at-home monitoring devices and smart device applications are used more and more to measure value and quality in cancer care. This trial may show whether at-home monitoring programs can improve the care of patients after hospital discharge from surgery.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- PROCEDURE Patient Monitoring
Study Locations (1)
California
- City of Hope Medical Center - Duarte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2019-12-24 |
| Est. Completion | 2025-10-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04501913
The ClinicalTrials.gov registry entry for NCT04501913 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 87-participant average among 10 other Clinical Stage II Esophageal Adenocarcinoma AJCC v8 trials with a reported enrollment target (75% lower). The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Clinical Stage II Esophageal Adenocarcinoma AJCC v8 appearing as the primary indexed condition, and to 2 interventions - of which Questionnaire Administration is the first listed.
NCT04501913 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04501913 about?
NCT04501913 is a clinical study titled "Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes". This study examines at-home monitoring of patient-generated phsyiologic health data and patient-reported outcomes. Patient-generated health data using at-home monitoring devices and smart device applications are used more and more to measure value and quality in cancer care. This trial may show whet...
What is the current status of trial NCT04501913?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2019-12-24. Estimated completion is 2025-10-17.
What conditions does trial NCT04501913 study?
This clinical trial studies the following conditions: Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Gastric Cancer AJCC v8, Clinical Stage I Gastric Cancer AJCC v8.
What interventions are being tested in trial NCT04501913?
The interventions under investigation include: Questionnaire Administration (OTHER), Patient Monitoring (PROCEDURE).
Who is sponsoring clinical trial NCT04501913?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04501913 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Clinical Stage II Esophageal Adenocarcinoma AJCC v8
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction Adenocarcinoma
RECRUITING · Phase 2
-
Preoperative Hypofractionated Radiotherapy With FOLFOX for Esophageal or Gastroesophageal Junction Adenocarcinoma
RECRUITING · Phase 2
-
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
RECRUITING · Phase 2
-
Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer
RECRUITING · Phase 3
-
NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer
RECRUITING · Phase 1
-
Feasibility of Auricular Acupressure for Appetite and Weight in Patients With Stage II-IV Gastric, Esophageal, and Pancreatic Cancer
RECRUITING · NA
Explore more on PlainTrial
Clinical Stage II Esophageal Adenocarcinoma AJCC v8
All registered trials for this condition
Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8
All registered trials for this condition
California
All trials with a study site in California
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.